SRI earns FDA Orphan Drug Designation for pancreatic cancer
SRI’s Targeted Antigen Loaded Liposomes (TALL) — a treatment that expands the benefits of immunotherapy such as check-point inhibitors —...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
SRI’s Targeted Antigen Loaded Liposomes (TALL) — a treatment that expands the benefits of immunotherapy such as check-point inhibitors —...
FOR IMMEDIATE RELEASECredit: Photo courtesy of Jelani Zarif FOR IMMEDIATE RELEASE A novel therapy that reprograms immune cells to promote...
Currently, the mechanism of occurrence and development of colonic polyps and colonic cancer has not been fully elucidated. Previous studies...
Breast cancer is one of the greatest global health concerns for women, with rising incidence rates and mortality projections, while...
OAK BROOK, Ill. – In a study of nearly 5,000 screening mammograms interpreted by an FDA-approved AI algorithm, patient characteristics...
WARSAW, POLAND — The National Comprehensive Cancer Network® (NCCN®)—a global nonprofit responsible for leading cancer treatment guidelines—is taking part in...
When cells become tumor cells, their metabolism changes fundamentally. Researchers at the University of Basel and the University Hospital Basel...
An exceptional $8 million, 10-year philanthropic investment will spearhead new treatments for pancreatic cancer and create a new dedicated research...
WINSTON-SALEM, N.C. – May 20, 2024 – Many breast cancer survivors report cancer-related cognitive impairment following chemotherapy, although prevalence rates and...
“ we have characterized a pair of compounds that impact multiple processes that are relevant to cancer cell proliferation but...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine